Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort by Bossuyt, Peter, Baert, Filip, D'Heygere, Francois, Nakad, Antoine, Reenaers, Catherine, Fontaine, Fernand, Franchimont, Denis, Dewit, Olivier, Van Hootegem, Philippe, Vanden Branden, Stijn, Lambrecht, Guy, Ferrante, Marc

Get full text

Systemic-to-pulmonary venous shunt in a haemodialysis patient by Tintillier, Michel, de Suraÿ, Nicolas, Alexis, Frédéric, Mathy, Isabelle, Rombaut, Emmanuel

Get full text

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial by Khanna, Reena, MD, Bressler, Brian, Prof, Levesque, Barrett G, MD, Zou, Guangyong, Prof, Stitt, Larry W, MSc, Greenberg, Gordon R, Prof, Panaccione, Remo, Prof, Bitton, Alain, Prof, Paré, Pierre, Prof, Vermeire, Séverine, Prof, D'Haens, Geert, Prof, MacIntosh, Donald, Prof, Sandborn, William J, Prof, Donner, Allan, Prof, Vandervoort, Margaret K, MSc, Morris, Joan C, MHSc, Feagan, Brian G, Prof

Get full text

Preoperative Predictors of Neoplasia in Patients Undergoing Small Bowel Resection for Complicated Crohn's Disease: A Multicentre Case-Control Study by Chappe, Capucine, Salut, Cecile, Amiot, Aurelien, Gaye, Delphine, Frulio, Nora, Lapuyade, Bruno, Vuitton, Lucine, Altwegg, Romain, Gilletta, Cyrielle, Fumery, Mathurin, Bouguen, Guillaume, Serrero, Melanie, Nachury, Maria, de Suray, Nicolas, Caillo, Ludovic, Simon, Mireille, Laharie, David, Rivière, Pauline, Poullenot, Florian

Get full text

Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies by Fierens, Liselotte, Liefferinckx, Claire, Hoefkens, Eveline, Lobatòn, Triana, Dreesen, Erwin, Sabino, João, Ferrante, Marc

Get full text